ATE447416T1 - Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit - Google Patents

Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit

Info

Publication number
ATE447416T1
ATE447416T1 AT03786628T AT03786628T ATE447416T1 AT E447416 T1 ATE447416 T1 AT E447416T1 AT 03786628 T AT03786628 T AT 03786628T AT 03786628 T AT03786628 T AT 03786628T AT E447416 T1 ATE447416 T1 AT E447416T1
Authority
AT
Austria
Prior art keywords
contrast agent
improved biological
agent formulations
formulations
biological tolerability
Prior art date
Application number
AT03786628T
Other languages
English (en)
Inventor
Milos Sovak
Allen Seligson
Ronald C Terry
Original Assignee
Biophysica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophysica Inc filed Critical Biophysica Inc
Application granted granted Critical
Publication of ATE447416T1 publication Critical patent/ATE447416T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03786628T 2002-12-12 2003-11-07 Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit ATE447416T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43287902P 2002-12-12 2002-12-12
US10/701,586 US7250153B2 (en) 2002-12-12 2003-11-05 Contrast media formulations having improved biological tolerance
PCT/US2003/035762 WO2004054637A2 (en) 2002-12-12 2003-11-07 Contrast media formulations having improved biological tolerance

Publications (1)

Publication Number Publication Date
ATE447416T1 true ATE447416T1 (de) 2009-11-15

Family

ID=34107426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03786628T ATE447416T1 (de) 2002-12-12 2003-11-07 Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit

Country Status (18)

Country Link
US (1) US7250153B2 (de)
EP (1) EP1575621B1 (de)
JP (1) JP2006509841A (de)
KR (1) KR101067159B1 (de)
CN (1) CN1738651A (de)
AT (1) ATE447416T1 (de)
AU (1) AU2003295442B2 (de)
CA (1) CA2509035C (de)
CY (1) CY1110105T1 (de)
DE (1) DE60329939D1 (de)
DK (1) DK1575621T3 (de)
ES (1) ES2333863T3 (de)
IL (1) IL169119A (de)
NO (1) NO332350B1 (de)
NZ (1) NZ541139A (de)
PT (1) PT1575621E (de)
SI (1) SI1575621T1 (de)
WO (1) WO2004054637A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1938050A (zh) * 2004-03-11 2007-03-28 马林克罗特公司 包含碘代单体以及二聚体混合物的x射线造影制剂
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
ES2391002T3 (es) * 2008-01-14 2012-11-20 Mallinckrodt Llc Proceso para la preparación de iosimenol
KR101915821B1 (ko) * 2010-03-23 2018-11-06 지이 헬스케어 에이에스 안정화된 ｘ―선 진단용 조성물의 제조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT371998B (de) * 1978-07-04 1983-08-25 Nyegaard & Co As Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
WO1997000240A1 (en) * 1995-06-16 1997-01-03 Biophysica Foundation Formyl derivatives as nonionic contrast media
DE19648650C2 (de) 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung

Also Published As

Publication number Publication date
WO2004054637A2 (en) 2004-07-01
IL169119A (en) 2010-06-16
DE60329939D1 (de) 2009-12-17
NO20053343D0 (no) 2005-07-08
US7250153B2 (en) 2007-07-31
JP2006509841A (ja) 2006-03-23
KR20050088312A (ko) 2005-09-05
SI1575621T1 (sl) 2010-01-29
KR101067159B1 (ko) 2011-09-22
US20050025711A1 (en) 2005-02-03
EP1575621A2 (de) 2005-09-21
EP1575621A4 (de) 2008-11-26
DK1575621T3 (da) 2009-12-14
CN1738651A (zh) 2006-02-22
NO20053343L (no) 2005-09-08
NO332350B1 (no) 2012-09-03
IL169119A0 (en) 2007-07-04
PT1575621E (pt) 2009-11-13
CA2509035C (en) 2011-07-19
AU2003295442A1 (en) 2004-07-09
CA2509035A1 (en) 2004-07-01
ES2333863T3 (es) 2010-03-02
CY1110105T1 (el) 2015-01-14
WO2004054637A3 (en) 2004-09-16
NZ541139A (en) 2008-07-31
AU2003295442B2 (en) 2008-11-06
EP1575621B1 (de) 2009-11-04

Similar Documents

Publication Publication Date Title
BRPI0516463A (pt) cánula escalonada e conjunto de cánula
CY1111844T1 (el) Angiopep-1, σχετικες ενωσεις, και χρησεις αυτων
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
BRPI0519047A2 (pt) mÉtodo para a produÇço de um agente de contraste marcador ou agente terapÊutico marcador, agentes de contraste marcadores e uso de agentes de contraste marcadores ou de agentes terapÊuticos marcadores
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
WO2003072195A3 (en) Method for administering glp-1 molecules
ITRM20010464A1 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
DE602004032522D1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
DK1472344T3 (da) Bakteriofaglysin
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
ATE326968T1 (de) Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer
CY1110105T1 (el) Σκευασματα σκιαγραφικων μεσων που εχουν βελτιωμενη ανεκτικοτητα
CY1107158T1 (el) Νεα παραγωγα της ισοκινολινης, η μεθοδος παρασκευης τους και η χρηση τους για τη θεραπεια των διαταραχων του μελατονινεργικου συστηματος
CY1109657T1 (el) Φαρμακευτικες συνθεσεις ηρεμιστικου υπνωτικου μεσου ταχειας δρασης
DK1713438T3 (da) Medicinsk sæbe
DE60041198D1 (de) Antimikrobielle zusammensetzungen
EP1281887A3 (de) Rundlager
YU83903A (sh) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
WO2006071949A3 (en) Zebrafish heterotrimer g-protein gamma 2 subunit (gng2)
DE602005008398D1 (de) Orale flüssige Citalopram enthaltende Formulierungen
GT200300260A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
ITTE20040002A1 (it) Sistema per la saldatura di "radiatori termoarredo".
DE602006016952D1 (de) Cnf1 bacterielles toxin-protein aus e. coli als analgetikum

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1575621

Country of ref document: EP